---
layout: default
title: Generalisation of automatic tumour segmentation in histopathological whole-slide images across multiple cancer types
---

# Generalisation of automatic tumour segmentation in histopathological whole-slide images across multiple cancer types

**arXiv**: [2510.11182v1](https://arxiv.org/abs/2510.11182) | [PDF](https://arxiv.org/pdf/2510.11182.pdf)

**ä½œè€…**: Ole-Johan Skrede, Manohar Pradhan, Maria Xepapadakis Isaksen, Tarjei Sveinsgjerd Hveem, Ljiljana Vlatkovic, Arild Nesbakken, Kristina Lindemann, Gunnar B Kristensen, Jenneke Kasius, Alain G Zeimet, Odd Terje Brustugun, Lill-Tove Rasmussen Busund, Elin H Richardsen, Erik Skaaheim Haug, BjÃ¸rn Brennhovd, Emma Rewcastle, Melinda Lillesand, VebjÃ¸rn Kvikstad, Emiel Janssen, David J Kerr, Knut LiestÃ¸l, Fritz Albregtsen, Andreas Kleppe

---

## ðŸ’¡ ä¸€å¥è¯è¦ç‚¹

**æå‡ºé€šç”¨è‚¿ç˜¤åˆ†å‰²æ¨¡åž‹ï¼Œåœ¨å¤šç§ç™Œç—‡ç±»åž‹ä¸­å®žçŽ°é«˜ç²¾åº¦åˆ†å‰²ã€‚**

**å…³é”®è¯**: `è‚¿ç˜¤åˆ†å‰²` `æ·±åº¦å­¦ä¹ ` `ç»„ç»‡ç—…ç†å­¦å›¾åƒ` `å¤šç™Œç—‡ç±»åž‹` `é€šç”¨æ¨¡åž‹`

## ðŸ“‹ æ ¸å¿ƒè¦ç‚¹

1. æ ¸å¿ƒé—®é¢˜ï¼šå¼€å‘å•ä¸€æ¨¡åž‹åœ¨ç»„ç»‡ç—…ç†å­¦å…¨åˆ‡ç‰‡å›¾åƒä¸­é€šç”¨è‚¿ç˜¤åˆ†å‰²ï¼Œé€‚åº”ä¸åŒç™Œç—‡ç±»åž‹ã€‚
2. æ–¹æ³•è¦ç‚¹ï¼šä½¿ç”¨æ·±åº¦å­¦ä¹ ï¼ŒåŸºäºŽè¶…è¿‡20000å¼ å…¨åˆ‡ç‰‡å›¾åƒè®­ç»ƒæ¨¡åž‹ï¼Œæ¶µç›–å››ç§ç™Œç—‡ç±»åž‹ã€‚
3. å®žéªŒæˆ–æ•ˆæžœï¼šåœ¨å¤–éƒ¨éªŒè¯é˜Ÿåˆ—ä¸­å¹³å‡Diceç³»æ•°è¶…è¿‡80%ï¼Œæ€§èƒ½ä¸Žä¸“ç”¨æ¨¡åž‹ç›¸å½“ã€‚

## ðŸ“„ æ‘˜è¦ï¼ˆåŽŸæ–‡ï¼‰

> Deep learning is expected to aid pathologists by automating tasks such as
> tumour segmentation. We aimed to develop one universal tumour segmentation
> model for histopathological images and examine its performance in different
> cancer types. The model was developed using over 20 000 whole-slide images from
> over 4 000 patients with colorectal, endometrial, lung, or prostate carcinoma.
> Performance was validated in pre-planned analyses on external cohorts with over
> 3 000 patients across six cancer types. Exploratory analyses included over 1
> 500 additional patients from The Cancer Genome Atlas. Average Dice coefficient
> was over 80% in all validation cohorts with en bloc resection specimens and in
> The Cancer Genome Atlas cohorts. No loss of performance was observed when
> comparing the universal model with models specialised on single cancer types.
> In conclusion, extensive and rigorous evaluations demonstrate that generic
> tumour segmentation by a single model is possible across cancer types, patient
> populations, sample preparations, and slide scanners.

